Differential impacts of allergic rhinitis and allergy medications on childhood learning

Pediatric Asthma, Allergy and Immunology

Volumn 12, Issue 1, 1998, Pages 1-13

  Bender, Bruce G ^a,c   Fischer, Thomas J ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; ANTIHISTAMINIC AGENT; CORTICOSTEROID; DECONGESTIVE AGENT; HYDROXYZINE; UNINDEXED DRUG;

ABSENTEEISM; ALLERGIC RHINITIS; ALLERGY; AMNESIA; CENTRAL NERVOUS SYSTEM; CHILD; CHILD BEHAVIOR; CLINICAL TRIAL; COGNITION; EDUCATION; EMOTION; HUMAN; LEARNING; NEUROTOXICITY; PRIORITY JOURNAL; REVIEW; SOMNOLENCE;

EID: 0031858391     PISSN: 08831874     EISSN: None     Source Type: Journal    
DOI: 10.1089/pai.1998.12.1     Document Type: Review

References (78)

1. Newacheck PW, Stoddard JJ. Prevalence and impact of multiple childhood chronic illnesses. J Pediatr 1994; 124:40-48.
2. Ricketti AJ. Seasonal Allergic Rhinitis. In: R Patterson, ed., Allergic Diseases: Diagnosis and Management. Philadelphia, PA: JB Lippincott, 1985, pp 207-230.
3. Avner SE, Kinsman RA. Psychologic factors and allergic diseases. In CW Bierman, DS Pearlman, eds. Allergic Diseases from Infancy to Adulthood. Philadelphia, PA: WB Saunders Co, 1988, pp 300-317.
4. Richards W. Preventing behavior problems in asthma and allergies. Clin Pediatrics 1994: 617-624.
5. Sly RM. Allergy and school problems. In CW Bierman, DS Pearlman, eds. Allergic Diseases of Infancy, Childhood, and Adolescence. Philadelphia, PA: JD Saunders, 1980, pp 746-750.
6. Simons FER. Learning impairment and allergic rhinitis. Allergy Asthma Proc 1996; 17:185-189.
7. Marshall PS, Colon EA. Effects of allergy season on mood and cognitive function. Ann Allergy 1993; 71:251-258.
8. Vuurman EFPM, van Veggel LMA, Uiterwijk MMC, Leutner D, O'Hanlon JF. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy 1993; 71:121-126.
9. Vuurman EFPM, van Veggel LMA, Sanders RL, Muntjewerff ND, O'Hanlon JF. Effects of semprex-D and diphenhydramine on learning in young adults with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1996; 76:247-252.
10. Feldman W, Shanon A, Leiken L, Ham-pong A, Peterson R. Central nervous system side-effects of antihistamines in schoolchildren. Rhinology 1992; 13(suppl):13-19.
11. Guill M, Buckley R, Rocha WJ, et al. Multicenter, double-blind, placebo-controlled trial of terfenadine suspension in the treatment of fall-allergic rhinitis in children. J Allergy Clin Immunol 1986; 78:4-9.
12. Clissold SP, Sorkin EM, Gola KL. Loratadine: A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1989; 37:42-57.
13. Barenholtz HA, McLeod DC. Loratadine: A nonsedating antihistamine with once-daily dosing. DICP. 1989; 23:445-450.
14. Klein GL, Ziering RW, Girsh LS, Miller MF. The allergic irritability syndrome: Four case reports and a position statement from the neuroallergy committee of the American College of Allergy. Ann Allergy 1985; 55:22-24.
15. Ziering RW. Immediate and late side effects of hay fever. Postgrad Med 1989; 85:183-188.
16. Juniper EF, Guyatt GH, Dolovich J. Clinical aspects of allergic disease. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: Development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 1994; 93:413-423.
17. Wright AL, Holberg CJ, Martinez FD, Halonen M, Morgan W, Taussig LM. Epidemiology of physician-diagnosed allergic rhinitis in childhood. Pediatrics 1994; 94:895-901.
18. Gerrard JW, Vickers P, Gerrard CD. The familial incidence of allergic disease. Ann Allergy 1976; 36:10-15.
19. Bender BG, Klinnert MD. Psychological correlates of asthma severity and treatment outcome in children. In H Kotses, A Harver, eds., Behavioral Contributions to the Management of Asthma. New York, NY: Marcel Dekker, 1998, pp. 63-84.
20. Kinsman RA, Dirks JF. Psychomaintenance in chronic physical illness: A new direction for psychosomatic medicine. Advances Psychol 1982; 1:1-8.
21. Yellowlees PM, Kalucy RS. Psychobiological aspects of asthma and the consequent research implications. Chest 1990; 97:628-634.
22. Mrazek DA. Psychiatric illness in severely asthmatic children. Papers on New Res Am Psychiatric Assoc. 1985;112.
23. Mrazek DA, Klinnert M. Asthma: Psyclioneuroimmunologic considerations. In R Ader, EL Felton, N Cohn, eds. Psychoneuroimmunology II. 5th ed. Orlando, FL: Academic Press, 1991, pp 1013-1035.
24. Miller B. Depression and asthma: A potentially lethal mixture. J Allergy Clin Immunol 1987; 80:481-486.
25. Mascia A, Frank S, Berkman A, et al. Mortality versus improvement in severe chronic asthma: Physiologic and psychologic factors. Ann Allergy 1989; 62:311-317.
26. Strunk RC, Mrazek DA, Wolfson GS, et al. Physiological and psychological characteristics associated with deaths from asthma in childhood: A case-controlled study. JAMA 1985; 254:1193-1198.
27. Mrazek DA. Psychiatric complications of pediatric asthma. Ann Allergy 1992; 69:285-293.
28. Meltzer EO. Evaluating rhinitis: Clinical, rhinomanometric, and cytologic assessments. J Allergy Clin Immunol 1988; 82:900-908.
29. McLoughlin J, Nall M, Isaacs B, Petrosko J, Karibo J, Lindsey B. The relationship of allergies and allergy treatment to school performance and student behavior. Ann Allergy 1983; 51:506-510.
30. Milgrom H, Bender B. Psychologic side effects of therapy with corticosteroids. Am Rev Respir Dis 1993; 147:471-473.
31. Bain D. Can the clinical course of acute otitis media be modified by systemic decongestant or antihistamine treatment? Br Med J 1983; 287:654-666.
32. Sills JA, Nunn AJ, Sankey RJ. Visual hallucinations in children receiving decongestants [letter]. Br Med J (Clin Res Ed) 1984; 288:1912-1913.
33. Peggs JF, Shimp LA, Opdyke RC. Antihistamines: The old and the new. Am Fam Physician 1995; 52:593-600.
34. 1 receptor antagonist treatment of chronic rhinitis. J Allergy Clin Immunol 1988; 81:975-980.
35. Physicians' Desk Reference. 51st ed. Montvale, NJ: Medical Economics Co, 1997, pp 1341-1343.
36. Hoechst Marion Roussel. Allegra (fexofenadine hydrochloride) capsules prescribing information.
37. Physicians' Desk Reference. 51st ed. Montvale, NJ: Medical Economics Co, 1997, pp 2485-2487.
38. Physicians' Desk Reference. 51st ed. Montvale, NJ: Medical Economics Co, 1997, pp 1284-1286.
39. Burns M, Shanaman JE, Shellenberger CH. A laboratory study of patients with chronic allergic rhinitis: Antihistamine effects on skilled performance. J Allergy Clin Immunol 1994; 93:716-724.
40. Goetz DW, Jacobson JM, Murnane JE, Reid MJ, Repperger DW, Goodyear C, Martin ME. Prolongation of simple and choice reaction times in a double-blind comparison of twice-daily hydroxyzine versus terfenadine. J Allergy Clin Immunol 1989; 84:316-322.
41. Nicholson AN, Smith PA, Spencer MB. Antihistamines and visual function: studies on dynamic acuity and the pupillary response to light. Br J Clin Pharmacol 1982; 14:683-690.
42. Nicholson AN. Central effects of H-1 and H-2 antihistamines. Aviat Space Environ Med 1985; 56:293-298.
43. Meador KJ, Loring DW, Thompson EE, Thompson WO. Differential cognitive effects of terfenadine and chlorpheniramine. J Allergy Clin Immunol 1989; 84:322-325.
44. Druce H. Impairment of function by antihistamines [editorial]. Ann Allergy 1990; 64:403-405.
45. Lutsky BN, Klose P, Melon J, Menardo JL, Molkhou P, Ronehetti R, Suonpää J, Wahn U, Wessel F. A comparative study of the efficacy and safety of loratadine syrup and terfenadine suspension in the treatment of 3- to 6-year-old children with seasonal allergic rhintis. Clin Ther 1993; 15:855-865.
46. Boner AL, Miglioranzi P, Richelli C, Marchesi E, Andreoli A. Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis. Allergy 1989; 44:437-441.
47. Falliers CJ, Brandon ML, Buchman E, Connell JT, Dockhorn R, Leese PT, Miller J, Wasserman SI, Zeterberg JM, Altman R, Love S, Samuels LL. Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis. Ann Allergy 1991; 66:257-262.
48. Roehrs RA, Tietz EI, Zorick FJ, Roth T. Daytime sleepiness and antihistamines. Sleep 1984; 7:137-141.
49. Meltzer EO, Weller JM, Widlitz MD. Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis. J Allergy Clin Immunol 1996; 97:617-626.
50. Physicians' Desk Reference. 51st ed. Montvale, NJ: Medical Economics Co, 1997, pp 2053-2055.
51. Ramaekers JG, Uiterwijk MMC, O'Hanlon JF. Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving. Eur J Clin Pharmacol 1992; 42:363-369.
52. DuBuske L. Dose-ranging comparative evaluation of cetirizine in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1995; 74:345-354.
53. Seidel WF, Cohen S, Bilwise NG, Dement WC. Cetirizine effects on objective measures of daytime sleepiness and performance. Ann Allergy 1987; 59(part 2):58-62.
54. Bender B, Milgrom H. Neuropsychiatric effects of medications for allergic diseases. J Allergy Clin Immunol 1995; 95:523-528.
55. Pauley TR, Marcrom RE. Safe and effective management of allergic rhinitis. American Druggist. March 1996, pp 50-57.
56. Good AP, Rockwood R, Schad P. Loratadine and ventricular tachycardias. Am J Cardiol 1994; 74:207-209.
57. Boner AL, Richelli C, Castellani C, Marchesi E, Andreoli A. Comparison of the effects of loratadine and astemizole in the treatment of children with seasonal allergic rhinoconjunctivitis. Allergy 1992; 47:98-102.
58. Schweitzer PK, Muehlbach MJ, Walsh JK. Sleepiness and performance during three-day administration of cetirizine or diphenhydramine. J Allergy Clin Immunol 1994; 94:716-724.
59. Lake CR, Masson EB, Quirk RS. Psychiatric side effects attributed to phenylpropanolamine. Pharmacopsychiatry 1988; 21:171-181.
60. Norvenius G, Widerlov E, Lonnerholm G. Phenylpropanolamine and mental disturbances [letter]. Lancet 1979; 2:1367-1368.
61. Stillwagon PK, Doyle WJ, Fireman P. Effect of an antihistamine/decongestant on nasal and Eustachian tube function following intranasal pollen challenge. Ann Allergy 1987; 58:442-446.
62. Kogan M, Pappas G, Yu SM, Kotelchuck M. Over-the-counter medication use among US preschool-age children. JAMA 1994; 272:1025-1030.
63. Corren J, Aaronson D, Beaucher W, Berkowitz R, Bronsky E, Chervinsky P, Cohen R, Grossman J, Meltzer E, Pedinoff A, Stricker W, Wanderer A, Fourre J, Chen R, Harris AG. A double-blind placebo controlled study of Claritan-D in patients with seasonal allergic rhinitis (SAR) and asthma. Presented at Collegium Internationale Allergologicum. September 6-11, 1996; Austria.
64. Bender BG, Lerner JA, Poland JE. Association between corticosteroids and psychologic change in hospitalized asthmatic children. Ann Allergy 1991; 66:414-419.
65. Bender B, Milgrom H. Adherence in pediatric asthma. Asthma Management 2000.
66. Creer TL, Stein REK, Rappaport L, Lewis C. Behavioral consequences of illness: Childhood asthma as a model. Pediatrics 1992; 90:808-815.
67. Strunk RC, Walker Boyd J. Today's Education. 1980; 69:70GE-76GE.
68. Brook U, Benjamini Y. Self-esteem of asthmatic children and adolescents: A pilot study. Pediatr Asthma Allergy Immunol 1993; 7:167-171.
69. Gortmaker SL, Walker DK, Weitzman M, Sobol AM. Chronic conditions, socioeconomic risks, behavioral problems in children and adolescents. Pediatrics 1990; 85:267-276.
70. Lewis CE, Rachelefsky G, Lewis MA, de la Sota A, Kaplan M. A randomized trial of A.C.T. (Asthma Care Training) for kids. Pediatrics 1984; 74:478-486.
71. Bender BG. Are asthmatic children educationally handicapped? School Psych Quarterly 1995; 10:274-291.
72. Fritz GK. Psychological issues in assessing and managing asthma in children. Clin Rev Allergy 1987; 5:259-271.
73. Mrazek DA. Avoiding behavioral problems in children with asthma. J Respir Dis 1987; 8:11-16.
74. Meltzer EO. Performance effects of antihistamines. J Allergy Clin Immunol 1990; 86:613-619.
75. Thach BT, Chase TN, Bosma JF. Oral facial dyskinesia associated with prolonged use of antihistamine decongestants. N Engl J Med 1975; 293:486-487.
76. Wynegaarden JB, Seevers MH. The toxic effects of antihistaminic drugs. JAMA 1951; 145:277-282.
77. King G, Weeks SD. Pyribenzamine activation of the electroencephalogram. Klectroencephalogr Clin Neurophysiol 1965; 18:503-507.
78. Koppel C, Ibe K, Tenczer J. Clinical symptomatology of diphenhydramine overdose: An evaluation of 136 cases in 1982 to 1985. J Toxicol Clin Toxicol 1987; 25:53-70.